Evaluación de Tecnología Sanitaria y su impacto en políticas de tarificación y cobertura de medicamentos / Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies
Rev. méd. Chile
; 142(supl.1): 33-38, ene. 2014. ilus, tab
Article
en Es
| LILACS
| ID: lil-708839
Biblioteca responsable:
CL1.1
ABSTRACT
The article conceptualizes the pharmaceutical pricing and reimbursement policies related to financial coverage in the context of health systems. It introduces the pharmaceutical market as an imperfect one, in which appropriate regulation is required. Moreover, the basis that guide the pricing and reimbursement processes are defined and described in order to generate a categorization based on whether they are intended to assess the 'added value' and if the evaluation is based on cost-effectiveness criteria. This framework is used to review different types of these policies applied in the international context, discussing the role of the Health Technology Assessment in these processes. Finally, it briefly discusses the potential role of these types of policies in the Chilean context.
Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Evaluación de la Tecnología Biomédica
/
Costos de los Medicamentos
/
Industria Farmacéutica
/
Reembolso de Seguro de Salud
/
Seguro de Servicios Farmacéuticos
Tipo de estudio:
Evaluation_studies
/
Health_economic_evaluation
/
Health_technology_assessment
Límite:
Humans
Idioma:
Es
Revista:
Rev. méd. Chile
Asunto de la revista:
MEDICINA
Año:
2014
Tipo del documento:
Article